Reuters: An insulin pill, long desired by diabetes doctors and patients, could be available by the end of this decade.
Reuters: An insulin pill, long desired by diabetes doctors and patients, could be available by the end of this decade.
In the pharma industry’s equivalent of a David and Goliath story, the companies at the forefront are Novo Nordisk, the world’s largest seller of insulin products with a market value of about $74 billion, and Oramed Pharmaceuticals Inc, with a market value of only $50 million and headquartered in Jerusalem, where the biblical David held court.
